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purpose
Previously published guidelines are available that provide comprehensive recommendations for detecting and preventing healthcare-associated infections (HAIs). The intent of this document is to highlight practical recommendations in a concise format designed to assist acute care hospitals in implementing and prioritizing their surgical site infection (SSI) prevention efforts. This document updates "Strategies to Prevent Surgical Site Infections in Acute Care Hospitals," 1 published in 2008. This expert guidance document is sponsored by the Society for Healthcare Epidemiology of America (SHEA) and is the product of a collaborative effort led by SHEA, the Infectious Diseases Society of America (IDSA), the American Hospital Association (AHA), the Association for Professionals in Infection Control and Epidemiology (APIC), and The Joint Commission, with major contributions from representatives of a number of organizations and societies with content expertise. The list of endorsing and supporting organizations is presented in the introduction to the 2014 updates. 2 section 1: rationale and statements of concern I. SSIs are common complications in acute care facilities A. SSIs occur in 2%-5% of patients undergoing inpatient surgery. 3, 4 B. Approximately 160,000-300,000 SSIs occur each year in the United States. 5, 6 C. SSI is now the most common and most costly HAI. [7] [8] [9] II. Outcomes associated with SSI A. Up to 60% of SSIs have been estimated to be preventable by using evidence-based guidelines. 10, 11 B. SSIs account for 20% of all HAIs in hospitalized patients. 12 C. Each SSI is associated with approximately 7-11 additional postoperative hospital-days. 3, 9, 13, 14 D. Patients with an SSI have a 2-11-times higher risk of death compared with operative patients without an SSI. 15, 16 1. Seventy-seven percent of deaths in patients with SSI are directly attributable to SSI. 17 E. Attributable costs of SSI vary depending on the type of operative procedure and the type of infecting pathogen.
figure 1. Centers for Disease Control and Prevention's National Healthcare Safety Network classification for surgical site infection (SSI). 215 
Deep incisional (involving fascia and/or muscular layers). a. Deep incision primary (DIP)-SSI identified in a primary incision in a patient who has had an operation with 1 or more incisions. b. Deep incision secondary (DIS)-SSI identified in
a secondary incision in a patient who has had an operation with more than 1 incision. 3. Organ/space (involving any part of the body opened or manipulated during the procedure, excluding skin incision, fascia, or muscle layers). II. Methods for surveillance of SSI A. The direct method with daily observation of the surgical site by the physician, physician extender, registered nurse, or infection prevention and control (IPC) professional starting 24-48 hours postoperatively is the most accurate method of surveillance. 13, [27] [28] [29] 1. While the direct method is used as the gold standard for studies, it is rarely used in practice because of its resource utilization requirements and impracticality. B. The indirect method of SSI surveillance consists of a combination of the following: 1. Review of microbiology reports and patient medical records. 2. Surgeon and/or patient surveys. 3. Screening for readmission and/or return to the operating room. 4. Other information, such as coded diagnoses, coded procedures, operative reports, or antimicrobials ordered. C. The indirect method of SSI surveillance is less timeconsuming and can be readily performed by IPC personnel during surveillance rounds. D. The indirect method of SSI surveillance is both reliable (sensitivity, 84%-89%) and specific (specificity, 99.8%) compared with the gold standard of direct surveillance. 30, 31 Components of the indirect methods that were associated with highest sensitivities included review of nursing notes, International Classification of Diseases, Ninth Revision codes, and antimicrobials used. E. Indirect methods for SSI surveillance are not reliable for surveillance of superficial incisional infections, particularly those occurring postdischarge. 32 F. Automated data systems can be used to broaden SSI surveillance. 1. SSI surveillance can be expanded by utilizing hospital databases that include administrative claims data (including diagnosis and procedure codes), antimicrobial-days, readmission to the hospital, and return to the operating room and/or by implementing a system that imports automated microbiologic culture data, surgical procedure data, and general demographic information into a single surveillance database. [33] [34] [35] 2. These methods improve the sensitivity of indirect surveillance for detection of SSI and reduce the effort of the infection preventionist. 33 3. Medicare claims data can be used to enhance traditional surveillance methods for SSI and to identify hospitals with unusually high or low rates of SSI. 36, 37 4. Use of administrative data can increase the efficiency of SSI reporting and validation. 38 III. Postdischarge surveillance A. Over the past 3 decades, advances in medical technology and changes in payment arrangements have increasingly shifted performance of surgical procedures from
Research is needed to better understand how definitions and postdischarge surveillance protocols developed for the acute care setting can be translated to the ambulatory care setting. 3. Superficial incisional SSIs are most commonly detected and managed in the outpatient setting. In contrast, deep incisional and organ/space infections typically require readmission to the hospital for management. 32 4. In the Netherlands, the proportion of deep SSIs identified after discharge from the hospital ranged from 6% for colon resections to 88% for knee arthroplasties. 43 The differences between these procedures could be explained by potential differences in both wound contamination class and the duration of postdischarge surveillance (30 days versus 1 year for an implant-related procedure). A pilot study in general surgery reported that 10.5% of SSIs following colon procedures were identified after discharge from the hospital. 52 5. By improving completeness of reporting, the overall institutional SSI rate typically increases after postdischarge surveillance methods are implemented regardless of which method is used. 43, 44, 53 a. To improve interfacility comparisons and minimize potential bias introduced by differences in postdischarge surveillance methods, national public reporting focuses on nonsuperficial incisional SSIs detected during hospitalization for the index procedure or after discharge and requiring readmission for management. The true effect may be substantially different from the estimated size and direction of the effect. Evidence is rated as low quality when supporting studies have major flaws, there is important variation between studies, the confidence interval of the summary estimate is very wide, or there are no rigorous studies, only expert consensus.
note. Based on Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) 234 and the Canadian Task Force on Preventive Health Care. 235 tion prevention recommendation is given a quality-of-evidence grade (see Table 1 ).
I. Basic practices for preventing SSI: recommended for all acute care hospitals 1. Administer antimicrobial prophylaxis according to evidence-based standards and guidelines (quality of evidence: I). 17, 75, 76 a. Begin administration within 1 hour before incision to maximize tissue concentration. 57, 58 Administering agent closer than 1 hour is effective, and some studies show superior efficacy for administration between 0 and 30 minutes prior to incision compared with administration between 30 and 60 minutes. 77, 78 i. Two hours are allowed for the administration of vancomycin and fluoroquinolones. ii. Many experts believe that antimicrobials should be infused prior to inflation of tourniquets in procedures using "bloodless" techniques, although data are insufficient to support this recommendation. 79, 80 b. Select appropriate agents on the basis of the surgical procedure, the most common pathogens causing SSIs for a specific procedure, and published recommendations. 76 c. Discontinue agent within 24 hours after surgery. 76 i. Although guidelines suggest stopping the antimicrobial agent within 24 hours of surgery, there is no evidence that agents given after closure contribute to efficacy, and they do contribute to increased resistance 81, 82 i. Prophylactic antimicrobials should be redosed at intervals of 2 half-lives (measured from time the preoperative dose was administered) in cases that exceed this time. f. Use a combination of parenteral antimicrobial agents and oral antimicrobials to reduce the risk of SSI following colorectal procedures. [84] [85] [86] [87] [88] [89] [90] [91] i. The additional SSI reduction achieved with mechanical bowel preparation has not been studied, but the data supporting use of oral antimicrobials have all been generated in combination with mechanical bowel preparation. ii. Mechanical bowel preparation without oral antimicrobials does not decrease the risk of SSI. 92 2. Do not remove hair at the operative site unless the presence of hair will interfere with the operation. Do not use razors (quality of evidence: II). 17, 93 a. If hair removal is necessary, remove hair outside the operating room using clippers or a depilatory agent. 3. Control blood glucose during the immediate postoperative period for cardiac surgery patients 58 (quality of evidence: I) and noncardiac surgery patients [94] [95] [96] [97] [98] 108 and total gastrectomy with esophagojejunal anastomosis 112 reported an approximate 40% decrease in the rate of SSI. Three of the studies reported protocols that included maintenance of perioperative normothermia and liberal fluid replacement. [106] [107] [108] iii. Two trials in mixed surgical populations undergoing emergency or elective laparotomy for gastrointestinal, gynecologic, or urologic procedures reported different results. 109, 110 (a) The large multicenter trial that restricted perioperative fluid replacement reported no difference. 109 A follow-up study performed in this population noted that patients undergoing cancer surgery who received 80% FiO 2 had higher rates of mortality than patients undergoing cancer surgery who received 30% FiO 2 .
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(b) The smaller trial without standardized protocols for perioperative normothermia or volume replacement reported an increase in SSIs. 110 In this study, the 80% FiO 2 group had a significantly higher proportion of patients with high body mass index (more than 30), higher blood loss, more crystalloid infused, and longer operations. This group also had 5 patients who remained intubated postoperatively (vs 1 in the 35% group). Postoperative intubation was predictive of SSI. b. A meta-analysis of 5 of the above-referenced studies concluded that perioperative supplemental oxygen led to a relative risk (RR) reduction of 25% for SSI. 114 6. Use alcohol-containing preoperative skin preparatory agents if no contraindication exists (quality of evidence: I). a. Alcohol is highly bactericidal and effective for preoperative skin antisepsis but does not have persistent activity when used alone. Rapid, persistent, and cumulative antisepsis can be achieved by combining alcohol with chlorhexidine gluconate or an iodophor. 115 i. Alcohol is contraindicated for certain procedures, including procedures in which the preparatory agent may pool or not dry (eg, involving hair) due to fire risk. Alcohol may also be contraindicated for procedures involving mucosa, cornea, or ear. b. The most effective disinfectant to combine with alcohol is unclear. i. A recent trial of 849 patients undergoing cleancontaminated surgery randomized patients to preoperative skin antisepsis with chlorhexidinealcohol or povidone-iodine. 116 The overall rate of SSI was significantly lower in the chlorhexidinealcohol group than in the povidone-iodine group (9.5% vs 16% [P p .004]; RR, 0.59 [95% confidence interval (CI), 0.41-0.85]). ii. In contrast, a single-center study compared povidone-iodine followed by isopropyl alcohol versus chlorhexidine-alcohol versus iodine-alcohol using a sequential implementation design. 117 General surgical patients who received skin antisepsis with iodine-alcohol had the lowest rates of SSI (3.9 per 100 procedures), compared with 6.4 per 100 procedures for patients who received povidone-iodine followed by alcohol and 7.1 per 100 procedures for patients who received chlorhexidine-alcohol.
iii. In the absence of alcohol, chlorhexidine gluconate may have advantages over povidone-iodine, in-cluding longer residual activity and activity in the presence of blood or serum. i. Procedures that require 90-day surveillance are determined by specific procedure codes. f. Surveillance should be performed on patients readmitted to the hospital. i. If an SSI is diagnosed at your institution but the surgical procedure was performed elsewhere, notify the hospital where the original procedure was performed. g. Develop a system for routine review and interpretation of SSI rates to detect significant increases or outbreaks and to identify areas where additional resources might be needed to improve SSI rates. 125 If increased rates are identified, determine the number of potentially preventable infections that occurred, defined as the number of SSIs that occurred during a procedure in which less than 100% of recommended practices and processes were completed. 10. Increase the efficiency of surveillance through utilization of automated data (quality of evidence: II). a. Implement a method to electronically transfer microbiology and operative data, including process measures when available, to IPC personnel to facilitate denominator data acquisition and calculation of SSI rates for various procedures. b. If information technology and infrastructure resources are available, develop automated methods for detection of SSIs utilizing automated data for readmissions, diagnosis and procedure codes, microbiology results, and antimicrobial dispensing. 35, [126] [127] [128] [129] c. Implementation of automated surveillance may improve the sensitivity of surveillance. 11. Provide ongoing feedback of SSI rates to surgical and perioperative personnel and leadership (quality of evidence: II). a. Routinely audit and provide confidential feedback on SSI rates and adherence to process measures to in-dividual surgeons, the surgical division and/or department chiefs, and hospital leadership. Several nonrandomized trials corroborate this conclusion. [138] [139] [140] c. Clinical practice guidelines from the American Society of Health-System Pharmacists recommend giving mupirocin intranasally to all patients with documented S. aureus colonization for orthopedic procedures, including total joint replacement and hip fracture repair, and cardiac procedures. d. Some trials demonstrate that preoperative screening for S. aureus, coupled with intranasal mupirocin and chlorhexidine bathing is effective in reducing SSI for some patients. i. For example, a randomized, double-blind, placebocontrolled, multicenter trial that evaluated rapid identification of S. aureus nasal carriers followed 
II Preoperative infections
Identify and treat infections (eg, urinary tract infection) remote to the surgical site prior to elective surgery. 17 Do not routinely treat colonization or contamination.
II Operative characteristics
Surgical scrub (surgical team members' hands and forearms)
Use appropriate antiseptic agent to perform preoperative surgical scrub. 17, 228 For most products, scrub the hands and forearms for 2-5 minutes.
II

Skin preparation
Wash and clean skin around incision site. Use a dual agent skin preparation containing alcohol, unless contraindications exist. ii. A double-blind randomized controlled trial involving more than 4,000 patients showed that intranasal application of mupirocin, which was not coupled with chlorhexidine bathing, did not significantly reduce the S. aureus SSI rate.
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(a) In a secondary analysis of these data, the use of intranasal mupirocin was associated with an overall decreased rate of nosocomial S. aureus infections among the S. aureus carriers. f. A recently published meta-analysis of 17 studies concluded that decolonization strategies prevent grampositive SSIs, S. aureus SSIs, and MRSA SSIs, although there was significant heterogeneity among the trials. 144 g. Factors that impact the decision to implement screening for S. aureus and decolonization include adherence to basic SSI prevention strategies, baseline rate of SSI due to S. aureus, individual patient risk factors for acquiring SSI due to S. aureus, availability of resources to implement the protocol, and ability to follow-up on protocol parameters (eg, laboratory results) and adherence. h. Routine preoperative decolonization with mupirocin without screening is not currently recommended. i. Mupirocin resistance has been documented. 145 
Perform antiseptic wound lavage (quality of evidence: II).
a. Wound lavage is a common practice, although the solution used for lavage differs among surgeons. ii. Studies of the efficacy of vancomycin prophylaxis were published prior to the emergence of community-acquired MRSA. b. Two meta-analyses of studies comparing glycopeptides to b-lactam antimicrobial prophylaxis concluded that there was no difference in rates of SSI between the 2 antimicrobial prophylaxis regimens. 144, 158 c. A meta-analysis of 6 studies concluded that prophylaxis with a glycopeptide and a second agent was protective against SSI due to gram-positive organisms compared with prophylaxis with a b-lactam alone. 144 Of note, the 2 randomized controlled trials included in the metaanalysis combined a glycopeptide with non-b-lactam antibiotic(s). Thus, no study has prospectively analyzed the effect of providing both glycopeptides and b-lactam antimicrobials for preoperative antimicrobial prophylaxis. As vancomycin does not have activity against gram-negative pathogens and appears to have less activity against MSSA than b-lactam agents, many experts recommend adding vancomycin to standard antimicrobial prophylaxis for the specific clinical circumstances described above.
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2. Do not routinely delay surgery to provide parenteral nutrition (quality of evidence: I). a. Preoperative administration of total parenteral nutrition has not been shown to reduce the risk of SSI in prospective randomized controlled trials and may increase the risk of SSI. 160, 161 b. Individual trials comparing enteral and parenteral perioperative nutrition and "immunomodulating" diets containing arginine and/or glutamine with "standard" control diets tend to have very small numbers and fail to show significant differences. Two recent meta-analyses, however, demonstrate reduction in postoperative infectious complication in patients receiving enteral diets containing glutamine and/or arginine administered either before or after the surgical procedure. In addition, one small study raised concern about higher rates of wound dehiscence while using these sutures. 167 d. 168 although this association may have been caused by one specific study. 169 Two trials (abdominal and cardiac surgical patients) compared iodophor-impregnated drapes to no drapes. 170, 171 While wound contamination was decreased in one trial, 170 neither trial demonstrated that iodophor-impregnated drapes decreased the rate of SSI. A nonrandomized retrospective study similarly concluded that impregnated drapes do not prevent SSIs after hernia repair. 172 IV. Unresolved issues 1. Preoperative bathing with chlorhexidine-containing products. a. Preoperative bathing with agents such as chlorhexidine has been shown to reduce bacterial colonization of the skin. 173 Several studies have examined the utility of preoperative showers, but none has definitively proven that they decrease SSI risk. A Cochrane review evaluated the evidence for preoperative bathing or showering with antiseptics for SSI prevention. 174 Six randomized controlled trials evaluating the use of 4% chlorhexidine gluconate were included in the analysis, with no clear evidence of benefit noted. It should be noted that several of these studies had methodological limitations and were conducted several years ago. Thus, the role of preoperative bathing in SSI prevention is still uncertain. i. To gain the maximum antiseptic effect of chlorhexidine, adequate levels of CHG must be achieved and maintained on the skin. Typically, adequate levels are achieved by allowing CHG to dry com-pletely. New strategies for preoperative bathing with chlorhexidine, such as preimpregnated cloths, have shown promise, 175, 176 but data are currently insufficient to support this approach. 2. Preoperative intranasal and pharyngeal chlorhexidine treatment for patients undergoing cardiothoracic procedures. a. Although data from a randomized controlled trial exist to support the use of chlorhexidine nasal cream combined with 0.12% chlorhexidine gluconate mouthwash, 177 chlorhexidine nasal cream is neither approved by the Food and Drug Administration (FDA) nor commercially available in the United States. 3. Use of gentamicin-collagen sponges.
a. Gentamicin-collagen sponges have been evaluated as a way to decrease SSI among colorectal and cardiac surgical patients. i. Colorectal surgical patients. Several single-center randomized trials have demonstrated that gentamicin-collagen sponges decrease the risk of SSI following colorectal procedures. [178] [179] [180] The rate of SSI was higher with the sponge, however, in a recent large, multicenter randomized clinical trial. 181 ii. Cardiothoracic surgical patients. Four randomized controlled trials have evaluated the use of gentamicin-collagen sponges in cardiothoracic surgery. Three of these trials demonstrated a decrease in SSIs, [182] [183] [184] and one showed no difference. 185 A recent meta-analysis combining these trials concluded that the risk of deep sternal wound infection was significantly lower in patients who received a gentamicin-collagen sponge than in patients who did not (RR, 0.62 [95% CI, 0.39-0.97]) despite significant heterogeneity among the trials. 186 b. Gentamicin-collagen sponges are not currently approved by the FDA for use in the United States. 4. Use of bundles to ensure compliance with best practices. a. Bundles have been promoted as methods to improve adherence to best practices. b. Although generally favorable, the use of bundles for the prevention of SSI has led to mixed results, depending on which components are included. 59, 187, 188 c. Thus, there is no consensus on the components of an effective bundle to prevent SSIs. i. Numerator: number of patients with appropriately maintained serum glucose (180 mg/dL or lower) in the time frame of 18-24 hours after anesthesia end time following cardiac surgery. ii. Denominator: total number of cardiac procedures performed. iii. Multiply by 100 so that the measure is expressed as a percentage. B. Outcome measures 1. SSI rate a. Use NHSN definitions and risk adjustment methods for SSI (available at http://www.cdc.gov/nhsn /acute-care-hospital/ssi/index.html). i. Numerator: number of patients with an SSI following selected operations. ii. Denominator: total number of selected operations performed. iii. Multiply by 100 so that the measure is expressed as the number of SSIs per 100 procedures.
iv. Rates of SSI can be risk adjusted using one of 2 methods: stratification using the NHSN risk index 133 or calculation of the standardized infection ratio (SIR). 189 NHSN now promotes the use of SIR over the NHSN risk index for improved risk adjustment potential, 190 and SIR is preferentially used for the national public reporting outcome measure within NHSN. (a) The NHSN risk index is an operation-and patient-specific prospectively applied risk score that predicts SSIs. 191 This risk index includes 3 predictors of increased risk of SSI: (1) estimators of wound microbial contamination, (2) duration of operation, and (3) markers for host susceptibility. 42 (b) SIR is the ratio of the observed number of SSIs (O) that occurred compared with the expected number for a surgeon performing a specific type of procedure (E; eg, SIR p O/E). 189 The expected number of SSIs can be obtained by multiplying the number of operations done by the surgeon in each procedure risk category by the NHSN rate for the same procedure risk category and dividing by 100. Values that exceed 1.0 indicate that more SSIs occurred than expected. Importantly, SIR can only be calculated if the number of expected HAIs is ≥1. Thus, this approach may be more difficult for small surgical programs or if few procedures are performed for any one procedure type. 192 (c) Risk adjustment using logistic regression and the SIR method generally provides better riskadjustment than the basic risk index. 190, 193 II. External reporting There are many challenges in providing useful information to consumers and other stakeholders while preventing unintended adverse consequences of public reporting of HAIs. 194 Recommendations and requirements for public reporting of HAIs have been provided by HICPAC, 195 the Healthcare-Associated Infection Working Group of the Joint Public Policy Committee, 54 the National Quality Forum, 55 and CMS. 196 The following is an example of an external performance measure that is currently required by some healthcare stakeholders and regulators. A. Process measures 1. Compliance with CMS antimicrobial prophylaxis guidelines (see the section above on internal reporting in "Section 5: Performance Measures" Senior management is responsible for ensuring that the healthcare system supports an infection prevention and control (IPC) program that effectively prevents healthcare-associated infections (HAIs) and the transmission of epidemiologically important pathogens Senior management is accountable for ensuring that an adequate number of trained personnel are assigned to the IPC program and adequate staffing of other departments that play a key role in HAI prevention (eg, environmental services) Senior management is accountable for ensuring that healthcare personnel, including licensed and nonlicensed personnel, are adequately trained and competent to perform their job responsibilities Direct healthcare providers (such as physicians, nurses, aides, and therapists) and ancillary personnel (such as environmental service and equipment processing personnel) are responsible for ensuring that appropriate IPC practices are used at all times (including hand hygiene, standard and isolation precautions, and cleaning and disinfection of equipment and the environment) Senior and unit leaders are responsible for holding personnel accountable for their actions IPC leadership is responsible for ensuring that an active program to identify HAIs is implemented, that HAI data are analyzed and regularly provided to those who can use the information to improve the quality of care (eg, unit staff, clinicians, and hospital administrators), and that evidence-based practices are incorporated into the program Senior and unit leaders are accountable for ensuring that appropriate training and educational programs to prevent HAIs are developed and provided to personnel, patients, and families Personnel from the IPC program, the laboratory, and information technology departments are responsible for ensuring that systems are in place to support the surveillance program section 6: examples of implementation strategies
Accountability is an essential principle for preventing HAIs. It provides the necessary translational link between science and implementation. Without clear accountability, scientifically based implementation strategies will be used in an inconsistent and fragmented way, decreasing their effectiveness in preventing HAIs. Accountability begins with the chief executive officer and other senior leaders who provide the imperative for HAI prevention, thereby making HAI prevention an organizational priority. Senior leadership is accountable for providing adequate resources needed for effective implementation of an HAI prevention program. These resources include necessary personnel (clinical and nonclinical), education, and equipment (Table 3) . The following information identifies implementation strategies that can be used as part of a program to prevent and reduce the risk for SSI. The implementation strategies are organized under 4 concepts: engage, educate, execute, and evaluate. 199 
I. Engage
In the engagement phase, there needs to be clear and effective communication pertaining to the reasons why the SSI implementation strategies are important for patient care. Engagement of senior leadership, physician champions, infection preventionists, and multidisciplinary teams are examples of strategies necessary for initial implementation of a program to reduce SSIs. The following implementation strategies are described in the literature as being essential for the engagement process. A. Obtaining support for SSI reduction from senior leadership. Senior leadership support is an important factor contributing to SSI rate decreases. Senior leadership is also critical for sustaining improvements over time.
Senior leadership can include but is not limited to the hospital's board, president, chief operating officer, chief medical officer, and chief nursing officer. 131, 202, 203 III. Execute In the execution phase, the focus is on implementation strategies to reduce barriers and improve adherence with evidence-based practices and reduce the risk of SSIs, including (a) standardization of care processes, (b) creating redundancy or independent checks, and (c) learning from defects when an SSI occurs. As noted above, no consensus exists on the components of an effective bundle to prevent SSIs. Thus, individual hospitals must identify local deficits and create their own bundle. A. Use a quality improvement methodology. Use of quality improvement methodology for designing and implementing a program leads to reduced rates of SSIs. Quality improvement methodologies include Lean Six Sigma, the Comprehensive Unit-Based Safety Program, and the Plan-Do-Check-Act model. Various performance improvement (PI) tools have been used, including dashboards, scorecards, and histograms, to display data. 149, 200, 203, 207, 211 B. Differentiate between adult and pediatric populations. Pediatric-focused evidence-based practices for reducing SSIs are lacking. Clinical interventions designed for the adult population cannot necessarily be transferred to the pediatric population. Hospital and pediatric surgeons must determine whether adult evidence-based interventions can be safely used with the pediatric population.
C. Use of information technologies (IT).
IT innovations can be used to simplify and standardize clinical documentation. IT and the electronic medical record can also be used for electronic surveillance, electronic prompts, automatic stops for prophylactic antibiotic orders, and education. Education can be delivered to patients, families, and healthcare workers through different media, including the Internet and television. 148, 202, 203, 212 D. Participation in a collaborative. Numerous studies have reported that participation in a collaborative can help reduce SSI rates in participating organizations. Collaboratives provide a mechanism for organizations to 1. Utilize valid data, such as with the American College of Surgeons National Surgical Quality Improvement Program; 213 2. Identify increased morbidity and mortality through comparisons to peer hospitals on a national basis; 213 and 3. Learn through the collaboration process. 161, 202, 203, 205, 207, 209, 213, 214 E. Use of preoperative/postoperative order sets. Standardized order sets can be developed on the basis of evidencebased practices. The order sets should be approved by the medical staff and updated when the evidence-based practices change. The development of order sets is a labor-intensive process necessitating skills and expertise of several disciplines, including surgery, anesthesia, nursing, and pharmacy. All relevant disciplines should be educated in the use of the order sets. 148, 202, 203 F. Acting on identified SSI issues. When issues suspected of increasing the risk of SSI are identified, the hospital should take action to resolve the identified issues. Several hospitals conduct root-cause analyses with a multidisciplinary team to identify the cause of the issues and any lack of adherence in the evidence-based practices. 149, [202] [203] [204] G. Establish a protocol for preoperative testing. Establish a protocol for procedure-specific preoperative testing to detect medical conditions that increase the risk of SSI. The protocol should focus on nutritional counseling if indicated, smoking cessation if indicated, preadmission infections, and reconciling medications with adjustments prior to surgery if indicated. 202 If high-risk patients are identified through screening, alerts should be added to electronic medical records to ensure that all members of the perioperative team are aware of the high-risk condition(s).
IV. Evaluate
In the evaluation phase, the focus is on the use of measurement and evaluation tools to determine the effectiveness of implementation strategies in the prevention of SSIs. A. Use of performance improvement tools. Various PI tools can be used. PI tools include dashboards, scorecards, or histograms to display data. Additional PI tools can include root-cause analysis and failure modes and effects analysis. 148, 202, 203 B. Direct observation of evidence-based practices. As part of a hospital's SSI improvement activities, trained observers (eg, infection preventionists, educators, nurses, and physicians) should observe surgery to assure that evidence-based practices have been implemented in the operating room. Direct observation can also be conducted for hand hygiene and surgical hand antisepsis technique. This activity is used to educate and reinforce evidence-based practices with the operating room practitioners. 136, 149, 203, 214 C. Longitudinal evaluation of SSI rates and compliance rates. Track the success of the SSI reduction program by evaluating SSI rates over time (ie, before, during, and after the program). If specific practices or processes are identified for improvement, evaluate the compliance with evidence-based practices related to these practices and processes. Feed these data evaluations back to frontline staff. 
